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Introduction
The true impact of Magnesium derangement is unknown
in critical illness. Conflicting reports in small studies have
been published regarding mortality and dysmagnesaemia
in critical care.
Objectives
We hypothesized that hypomagnesaemia would be asso-
ciated with adverse outcomes following critical care.
Methods
We performed a two center observational study of patients
treated in medical and surgical intensive care units in Bos-
ton, Massachusetts. All data was obtained from the
Research Patient Data Registry at Partners HealthCare.
We studied 81,061 patients, age ≥ 18 years, who received
critical care between 1997 and 2012 and who survived
72 hours following ICU admission. We excluded patients
with End Stage Renal Disease. The exposure of interest
was the lowest serum Magnesium measured in the
24 hours prior and 72 hours after ICU admission categor-
ized a priori as < 1.4 mEq/L, 1.4-1.7 mEq/L and >1.7
mEq/L. The primary outcome was 30-day all-cause mor-
tality determined by the US Social Security Administration
Death Master File. Adjusted odds ratios for 30-day mortal-
ity were estimated by multivariable logistic regression
models with inclusion of terms for gender and the Acute
Organ Failure score [[1]], a validated ICU risk-prediction
score inclusive of terms for age, race, comorbidity, patient
type (surgical vs medical), sepsis and acute organ failure.
Results
The cohort (N = 81,061) had 58% men, 80% white race,
52% surgical patients, 12% with sepsis, and a mean age of
62 years. 30-day mortality was 9% and 30-day hospital
readmission was 14.2%. In patients with magnesium < 1.4
mEq/L, 1.4-1.7 mEq/L and >1.7 mEq/L the 30 day
mortality rate was 9%, 8% and 10% respectively. The
adjusted odds of 30-day mortality in patients with Mg <
1.4 mEq/L was 0.94 (95%CI 0.87-1.01) and with Mg >1.7
mEq/L was 1.22 (95%CI 1.15-1.29), both relative to
patients with Mg 1.4-1.7 mEq/L. The AUC for the model
was 0.79 indicating good discrimination for 30-day mortal-
ity. Further, in medical ICU patients (N= 39,041), adjusted
odds of 30-day mortality in patients with Mg < 1.4 mEq/L
was 1.02 (95%CI 0.92-1.13; P = 0.70) and with Mg > 1.7
mEq/L was 1.45 (95%CI 1.35-1.56; P < 0.001), both relative
to patients with Mg 1.4-1.7 mEq/L. Additional adjustment
by acute kidney injury (RIFLE class injury or failure)
or chronic kidney disease stage did not alter the Mg-
mortality association. Finally, in patients with nutrition
status determined (N = 6,923) there was no significant
difference in serum Mg relative to nutrition status
(ANOVA P-value < 0.001).
Conclusions
In this large population of critically ill adults, hypermagne-
saemia near ICU admission in medical ICU patients is
associated with short term mortality. Hypomagnesaemia
does not appear to be associated with adverse outcome.
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